No results for ‘’
ERIS Lifesciences Ltd
NSE: ERIS BSE: 540596
₹1458.20
(9.13%)
Mon, 25 May 2026, 06:57 pm
Market Cap185.28B
PE Ratio46.05
Dividend0.55
Health Technology
Pharmaceuticals: Major
24.5KERIS Lifesciences Ltd About
ERIS Lifesciences manufactures, markets, and sells generic drugs. The Company provides a wide range of products in chronic and acute therapy segments which includes capsules, tablets, and sachets. Eris Lifesciences also focuses on hypertension, anti-diabetes, metabolic disorders, lipid lowering, and therapeutic areas. Eris Lifesciences serves the pharmaceutical markets in India.
Industry
Pharmaceuticals - Indian - Formulations
Founded
2007
Headquarters
CEO
Amit Indubhushan Bakshi
Employees
Contact
Website
http://www.eris.co.in
complianceofficer@erislifesciences.com
Phone
91-79-30451000
Location
8th Floor Commerce House -IV, Prahladnagar 100 FT Road, Ahmedabad, Gujarat, 380015